Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
361.30    0.00 (0.00%)
Bid:
334.00
Ask:
371.00
Spread: 37.00 (11.078%)
Market Cap: £7.42b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Holding(s) in Company

3 Sep 2013 13:45

RNS Number : 1238N
Marks & Spencer Group PLC
03 September 2013
 



 

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

 

MARKS AND SPENCER GROUP PLC

 

2. Reason for the notification (please place an X inside the appropriate bracket/s):

 

An acquisition or disposal of voting rights: (X)

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )

 

An acquisition or disposal of instruments of similar economic effect to qualifying financial instruments: ( )

 

An event changing the breakdown of voting rights: (X)

 

Other (please specify): ( )

 

 

3. Full name of person(s) subject to the notification obligation (iii):

 

BLACKROCK INC

 

4. Full name of shareholder(s) (if different from 3.) (iv):

 

AS ABOVE

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

 

30 AUGUST 2013

 

6. Date on which issuer notified:

 

3 SEPTEMBER 2013

 

7. Threshold(s) that is/are crossed or reached:

 

ABOVE 5%

 

8. Notified details:

……………..

 

A: Voting rights attached to shares (viii, xi)

 

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction

Number of shares

Number of voting Rights (viii)

ORDINARY 25P SHARES

ISIN: GB0031274896

N/A

N/A

 

 

Resulting situation after the triggering transaction

 

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights (ix)

% of voting rights (x)

Direct (xi)

Indirect (xii)

Direct

Indirect

ORDINARY 25P SHARES

ISIN: GB0031274896

NOT DISCLOSED

NOT DISCLOSED

80,710,707

NOT DISCLOSED

5%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration Date (xiii)

Exercise/Conversion Period/ Date (xiv)

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

(xv,xvi)

Type of financial instrument

Exercise price

Expiration Date (xvii)

Exercise/Conversion Period (xviii)

Number of voting rights instrument refers to.

% of voting rights (xix,xx)

Nominal

Delta

CFD

189,370

0.01%

0.01%

 

Total (A+B+C)

Number of voting rights

% of voting rights

80,900,077

5.01%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xxi):

 

BlackRock Investment Management (UK) Limited - 80,900,077 (5.01%)

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

 

11. Number of voting rights proxy holder will cease to hold:

 

N/A

 

12. Date on which proxy holder will cease to hold voting rights:

 

N/A

 

13. Additional information:

 

N/A

 

14. Contact name:

 

ANTHONY CLARKE

 

15. Contact telephone number:

 

020 8718 9940

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLJMTTMBIMBJJ
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSTotal Voting Rights
2nd Jan 20269:00 amRNSBlock listing Interim Review
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.